Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.
SciFluor Life Sciences announced that an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) is now in effect for SF0166 Topical Ophthalmic Solution, ... Read more
Swiss Advanced Vision, a company that designs, manufactures, and distributes a new generation of intraocular lenses for cataract surgery, recently announced a new product for post-cataract surgery, ... Read more
Omeros Corporation a company focused on discovering, developing and commercializing small-molecule and protein therapeutics, recently announced that the EMA (European Medicines Agency) Committee for Medicinal Products ... Read more
Icon Bioscience Inc., a biopharmaceutical company focused on developing and commercializing ophthalmic pharmaceuticals based on its proprietary Verisome drug delivery technology, recently announced positive data regarding their Phase ... Read more
Ocular Therapeutix, Inc. recently announced topline results of their second of two Phase 3 trials evaluating the efficacy and safety of their candidate drug OTX-DP, a compound that releases ... Read more
According to a recent study published in the American Journal of Ophthalmology, anterior capsule tears during cataract surgery may need additional surgical procedures, leading to intraoperative complications and permanent ... Read more
Pin It on Pinterest